15 insiders have filed at VCYT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Stapley Marc | Chief Executive Officer | 449.7k | 0.553% | 10 sells $4.2M | |
| Chambers Rebecca | Chief Financial Officer | 180.5k | 0.222% | 8 sells $2.5M | |
| Mcguire Annie | SVP, General Counsel | 153.9k | 0.189% | 11 sells $2.0M | |
| Febbo Phillip G. | Chief Scientific & Med Officer | 153.5k | 0.189% | 5 sells $1.2M | |
| Leite John | Chief Commercial Officer-Clia | 150.3k | 0.185% | 11 sells $1.2M | |
| Epstein Robert S | Director | 62.4k | 0.077% | 2 sells $1.3M | |
| Barr Eliav | Director | 51.2k | 0.063% | ||
| Wygant Jonathan | VP, Chief Accounting Officer | 45.4k | 0.056% | 4 sells $707k | |
| Bhanji Muna | Director | 39.3k | 0.048% | 3 sells $233k | |
| Bishop John L | Director | 33.1k | 0.041% | 2 sells $605k | |
| Jones Evan/ Fa | Director | 29.4k | 0.036% | 26 sells $5.9M | |
| Holstein Jens | Director | 27.2k | 0.033% | 7 sells $691k | |
| Miller Thomas F. | Director | 25.8k | 0.032% | ||
| Shafer David Brent | Director | 25.8k | 0.032% | ||
| Eastham Karin | Director | 13.6k | 0.017% | 14 sells $2.9M |
Full register at boothcheck.com/insiders/VCYT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.